Brazilian Health Regulator Anvisa Authorizes Trials for GSK-Medicago COVID Vaccine Brazilian Health Regulator Anvisa Authorizes Trials for GSK-Medicago COVID Vaccine

Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for a new COVID vaccine developed by Canada ' s Medicago and GlaxoSmithKline, Anvisa said in a statement.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news